B-cell Lymphoma
Showing NaN - NaN of 11
Follicular Lymphoma, B-Cell Lymphoma, Mantle Cell Lymphoma Trial in New York (Tazemetostat Pill)
Not yet recruiting
- Follicular Lymphoma
- +3 more
- Tazemetostat Pill
-
New York, New YorkWeill Cornell Medicine/NewYork-Presbyterian Hospital
Jun 28, 2023
B-Cell Lymphoma, Large B-cell Lymphoma, DLBCL, Nos Genetic Subtypes Trial in New York (19(T2)28z1xx TRAC T cell)
Recruiting
- B-Cell Lymphoma
- +4 more
- 19(T2)28z1xx TRAC T cell
-
New York, New YorkMemorial Sloan Kettering Cancer Center (All Protocol Activities)
Feb 24, 2023
Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-cell Marginal Zone, Lymphoma, Non-Hodgkin Trial in Worldwide (LOXO-338,
Active, not recruiting
- Leukemia, Lymphocytic, Chronic, B-Cell
- +6 more
-
Duarte, California
- +8 more
Jan 11, 2023
B-cell Malignancy, Non-Hodgkin Lymphoma, B-cell Lymphoma Trial in Worldwide (CTX110)
Recruiting
- B-cell Malignancy
- +3 more
- CTX110
-
Los Angeles, California
- +27 more
May 6, 2022
Relapsed or Refractory Lymphoproliferative Malignancies, Hodgkin's Lymphoma, Peripheral T-cell Lymphoma Trial in United States
Completed
- Relapsed or Refractory Lymphoproliferative Malignancies
- +4 more
- Pralatrexate Injection
- +3 more
-
Los Angeles, California
- +14 more
Dec 27, 2019
Marginal Zone Lymphoma, B-cell Lymphoma Trial in Worldwide (ibrutinib)
Completed
- Marginal Zone Lymphoma
- B-cell Lymphoma
-
Tucson, Arizona
- +24 more
Oct 8, 2019
Follicular Lymphoma, B-cell Lymphoma, Non-Hodgkin's Lymphoma Trial in United States (Ibrutinib, rituximab)
Completed
- Follicular Lymphoma
- +2 more
-
Burbank, California
- +11 more
Mar 26, 2019
B-Cell Lymphoma Trial in New York, Villejuif, Sheffield (half cyclophosphamide, without COPADM3, mini CYVE, without 3
Completed
- B-Cell Lymphoma
- half cyclophosphamide
- +4 more
-
New York, New York
- +2 more
Mar 27, 2012